The contemporary role of radiation therapy in the management of lung cancer

Surgical Oncology Clinics of North America

Volumn 9, Issue 3, 2000, Pages 539-561

  Mehta, M P ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYTOTOXIC AGENT;

BEAM THERAPY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PNEUMONIA; POSTOPERATIVE PERIOD; RADIATION DOSE FRACTIONATION; REVIEW; SKULL IRRADIATION;

EID: 0033945164     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30139-x     Document Type: Review

References (39)

1. Albain K. Rusch V. Crowley J. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for Stages IIIA (N2) and IIIB non-small cell lung cancer: Mature results of Southwest Oncology Group Phase II Study 8805 J Clin Oncol 13 1995 1880 1892
2. Anonymous: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials: Non-Small Cell Lung Cancer Collaborative Group BMJ 311 1995 899 909
3. Anonymous: Effects of post-operative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung: The Lung Cancer Study Group N Engl J Med 315 1986 1377 1381
4. Anonymous: Post-operative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomized controlled trials: PORT Meta-analysis Trialists Group Lancet 352 1998 257 263
5. Arriagada R. Auperin A. Pignon T.P. Prophylactic cranial irradiation overview (PCIO) in patients with small cell lung cancer (SCLC) in complete remission (CR J Clin Oncol 17 1998 1758
6. Arriagada R. LeChevalier T. Borie F. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission J Natl Cancer Inst 87 1995 183 190
7. Brodin O. Nou E. Mercke C. Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung Eur J Cancer 32 1996 1893 1900
8. Buccheri G. Ferrigno D. Therapeutic options for regionally advanced non-small cell lung cancer Lung Cancer 14 1996 281 300
9. Byhardt R. Pajak T. Emami B. A Phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno and large cell carcinoma of the lung: Report of Radiation Therapy Oncology Group 84-07 Int J Radiat Oncol Biol Phys 26 1993 459 468
10. Byhardt R. Scott C. Ettinger D. Concurrent hyperfractionated irradiation and chemotherapy for unresectable non-small cell lung cancer: Results of Radiation Therapy Oncology Group (RTOG) 90-15 Cancer 75 1995 2337 2344
11. Cox J. Holoya P. Byhardt R. The role of thoracic and cranial irradiation for smallcell carcinoma of the lung Int J Radiat Oncol Biol Phys 8 1982 191 196
12. Dillman R. Herndon J. Seagren S. Improved survival in Stage III non-small cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 1996 1210 1215
13. Einhorn L.H. Neoadjuvant and adjuvant trials in non-small-cell lung cancer Ann Thorac Surg 65 1998 208 211
14. Furuse K. Fukuoka M. Takada Y. Phase III study of concurrent vs. sequential thoracic radiotherapy (TRT) in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer: Five-year median follow-up results J Clin Oncol 18 1999 1770
15. Jeremic B. Shibamoto Y. Acimovic L. Hyperfractionated radiation therapy with or without concurrent low dose daily carboplatin/etoposide for Stage III non-small cell lung cancer: A randomized study J Clin Oncol 14 1996 1065 1070
16. Jeremic B. Shibamoto Y. Pre-treatment prognostic factors in patients with Stage III nonsmall cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy Lung Cancer 13 1995 21 30
17. Johnson D.H. Einhorn L.H. Bartolucci A. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small-cell lung cancer Ann Intern Med 113 1990 33 38
18. Keller S.M. Adak S. Wagner H. Prospective randomized trial of post-operative adjuvant therapy in patients with completely resected stages II and Ilia non-small-cell lung cancer: An Intergroup trial (E3590) J Clin Oncol 18 1999 1793
19. Landis S.H. Murray T. Bolden S. Cancer statistics, 1999 CA Cancer J Clin 49 1999 8 31
20. Le Chevalier T. Arriagada R. Quoix E. Radiotherapy alone vs. combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: First analysis of a randomized trial in 353 patients J Natl Cancer Inst. 83 1991 417 423
21. Lee J. Scott C. Komaki R. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancer: Radiation Therapy Oncology Group Protocol 91-06 J Clin Oncol 14 1996 1055 1064
22. Marino P. Preatoni A. Cantoni A. Randomized trials of radiotherapy alone vs. combined chemotherapy and radiotherapy in Stages Ilia and Mb non-small cell lung cancer: A meta-analysis Cancer 76 1995 593 601
23. Martel M.K. Ten Haken R. Mazuka M. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients Lung Cancer 24 1999 31 37
24. Mehta M.P. Tannehill S.P. Froseth C. A Phase II trial of hyperfractionated accelerated radiation therapy (HART) for locally advanced unresectable non-small cell lung cancer (NSCLC): Results of Eastern Cooperative Oncology Group trial 4593 J Clin Oncol 16 1998 3518 3523
25. Nugent J. Bunn P. Matthews M. CNS metastases in small-cell bronchogenic carcinoma: Increasing frequency and changing patterns with lengthening of survival Cancer 44 1979 1885 1893
26. Perez C.A. Bauer M. Edelstein S. Impact of tumor control on survival in carcinoma of the lung treated with irradiation Int J Radiat Oncol Biol Phys 12 1986 539 547
27. Perry M. Eaton W. Propert K. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung N Engl J Med 316 1987 912 918
28. Pignon J. Arriagada R. Ihde D. A meta-analysis of thoracic radiotherapy for smallcell lung cancer N Engl J Med 327 1992 1618 1624
29. Reboul F. Brewer Y. Vincent P. Concurrent cisplatin, etoposide and radiotherapy for unresectable Stage III non-small cell lung cancer: A Phase II study Int J Radiat Oncol Biol Phys 35 1996 343 350
30. Saunders M. Dische S. Barrett A. Randomized multicentre trials of chart vs. conventional radiotherapy in head and neck and non-small cell lung cancer: An interim report Br J Cancer 73 1996 1455 1462
31. Sause W. Scott C. Taylor S. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a Phase III trial in regionally advanced, unresectable non-small cell lung cancer J Natl Cancer Inst 87 1995 198 205
32. Schaake-Koning C. van den Bogaert W. Dalesio O. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer N Engl J Med 326 1992 524 530
33. Shaw E. McGinnis W. Jett J. Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable Stage III non-small cell carcinoma of the lung J Natl Cancer Inst 85 1993 321 323
34. Sibley G.S. Radiotherapy for patients with medically inoperable Stage I non-small-cell lung carcinoma Cancer 82 1998 433 438
35. Sundaresan N. Hilaris B.S. Martini N. The combined neurosurgical-thoracic management of superior sulcus tumors J Clin Oncol 5 1987 1739 1745
36. Trovo M. Minatel E. Franchin G. Radiotherapy vs. radiotherapy enhanced by cisplatin in Stage III non-small cell lung cancer Int J Radiat Oncol Biol Phys 24 1992 11 15
37. Turrisi A. Kim K. Blum R. Twice daily compared to once daily thoracic radiotherapy in small-cell lung cancer treated concurrently with cisplatin and etoposide N Engl J Med 340 1991 265 271
38. Warde P. Payne D. Does thoracic irradiation improve survival and local control in limited state small-cell carcinoma of the lung? A meta-analysis J Clin Oncol 10 1992 890 895
39. Wilson G. Sanders M. Dische S. Direct comparison of bromodeoxyuridine and Ki-67 labeling indices in human tumors Cell Prolif 29 1996 141 152